MetLife (MET) Stock Price, News & Analysis

Company Overview

MetLife, Inc. is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs. The company also offers retirement plan services and institutional investment solutions through its affiliated asset management operations, serving pension funds, insurers and other large clients. Distribution methods include direct sales, brokers and agents, bancassurance partnerships, and workplace channels.

MetLife operates across multiple regions, with significant activity in the United States, Asia, Latin America and EMEA. Its multinational footprint combines local market operations with centralized capabilities in product development, underwriting and asset management to serve both retail and corporate customers. The company has pursued strategic portfolio adjustments over time, including the 2017 spinoff of Brighthouse Financial, to focus on core insurance and employee-benefit franchises.

Founded in 1868 as the Metropolitan Life Insurance Company, MetLife converted from a mutual company to a publicly traded company in 2000. As of 2024, Michel A. Khalaf serves as president and chief executive officer, leading the company’s strategic priorities across its global businesses. MetLife remains known for its long history in the insurance industry and its broad suite of products for individuals, employers and institutions.

Key Stats

• Today's Range: $80.04 to $81.59
• 50-Day Range: $67.63 to $80.23
• 52-Week Range: $67.33 to $83.85
• Volume: 3.28 million shs
• Average Volume: 3.28 million shs
• Market Capitalization: $52.31 billion
• P/E Ratio: 17.07
• Dividend Yield: 2.83%
• Price Target: $93.38
• Consensus Rating: Moderate Buy

MetLife Stock Analysis - MarketRank™

MetLife scored higher than 99% of companies evaluated by MarketBeat, and ranked 12th out of 879 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

MetLife has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 1 strong buy rating, 11 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

MetLife has a consensus price target of $93.38, representing about 16.4% upside from its current price of $80.23.

Amount of Analyst Coverage

MetLife has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 11.65%

Earnings Growth

Earnings for MetLife are expected to grow by 11.65% in the coming year, from $9.87 to $11.02 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of MetLife is 17.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.22.

Price to Earnings Ratio vs. Sector

The P/E ratio of MetLife is 17.07, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 23.16.

Price to Earnings Growth Ratio

MetLife has a PEG Ratio of 0.71. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

MetLife has a P/B Ratio of 1.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.93% of the float of MetLife has been sold short.

Short Interest Ratio / Days to Cover

MetLife has a short interest ratio ("days to cover") of 3.73, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MetLife has recently decreased by 11.15%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

MetLife pays a meaningful dividend of 2.84%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

MetLife has been increasing its dividend for 12 years.

Dividend Coverage

The dividend payout ratio of MetLife is 48.30%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, MetLife will have a dividend payout ratio of 20.60% next year. This indicates that MetLife will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.70

News Sentiment

MetLife has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 23 news articles for MetLife this week, compared to 9 articles on an average week.

Search Interest

Only 11 people have searched for MET on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

14 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MetLife insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.35% of the stock of MetLife is held by insiders.

Percentage Held by Institutions

94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MET Stock Analysis - Frequently Asked Questions

How have MET shares performed this year?

MetLife's stock was trading at $78.98 on January 1st, 2026. Since then, MET stock has increased by 1.6% and is now trading at $80.2250.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) issued its quarterly earnings results on Wednesday, May, 6th. The financial services provider reported $2.42 EPS for the quarter, topping the consensus estimate of $2.27 by $0.15. The business's revenue for the quarter was up 2.7% compared to the same quarter last year.

Is MetLife doing a stock buyback?

MetLife's board authorized a share buyback plan on Wednesday, April 30th 2025, which permits the company to repurchase $3,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 5.9% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board of directors believes its shares are undervalued.

Does MetLife have any subsidiaries?

MetLife subsidiaries include Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and others.

Who are MetLife's major shareholders?

Top institutional shareholders of MetLife include Pzena Investment Management LLC (1.73%), Bank of New York Mellon Corp (0.55%), Swedbank AB (0.41%) and Jennison Associates LLC (0.40%). Insiders that own company stock include Ramy Tadros, Marlene Debel, Bill Pappas and Jeh C Johnson.
View institutional ownership trends.

How do I buy shares of MetLife?

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), ExxonMobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

• Record date for 3/10 Dividend: 2/03/2026
• Ex-Dividend for 3/10 Dividend: 2/03/2026
• Dividend Payable: 3/10/2026
• Today: 5/06/2026
• Last Earnings: 5/06/2026
• Next Earnings (Confirmed): 5/06/2026
• Record date for 6/9 Dividend: 5/12/2026
• Ex-Dividend for 6/9 Dividend: 5/12/2026
• Dividend Payable: 6/09/2026
• AGM 2026: 6/16/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: INS - MULTI LINE
• Sub-Industry: Life & Health Insurance
• Current Symbol: NYSE:MET
• CIK: 1099219
• Web: www.metlife.com
• Phone: (212) 578-9500
• Fax: 212-578-3320
• Employees: 46,000
• Year Founded: 1868

Price Target and Rating

• Average Price Target for MetLife: $93.38
• High Price Target: $103.00
• Low Price Target: $84.00
• Potential Upside/Downside: +16.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.93
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.70
• Trailing P/E Ratio: 17.07
• Forward P/E Ratio: 8.13
• P/E Growth: 0.71
• Net Income: $3.38 billion
• Net Margins: 4.38%
• Pretax Margin: 6.05%
• Return on Equity: 21.81%
• Return on Assets: 0.87%

Debt

• Debt-to-Equity Ratio: 0.52
• Current Ratio: 0.20
• Quick Ratio: 0.20

Sales & Book Value

• Annual Sales: $77.08 billion
• Price / Sales: 0.68
• Cash Flow: $7.78 per share
• Price / Cash Flow: 10.31
• Book Value: $43.53 per share
• Price / Book: 1.84

Miscellaneous

• Outstanding Shares: 652,050,000
• Free Float: 649,772,000
• Market Cap: $52.31 billion
• Optionable: Optionable
• Beta: 0.78